Prognosis

Note:

Common cancers cause malignant pleural effusions

men c	%  (95% CI)	women	%  (95% CI)
lung	49%  (43% to 55%)	breast	37%  (31% to 44%)
lymphoma/ leukaemia	21%  (16% to 26%)	female genital tract	20%  (15% to 26%)
GI tract	7.0%  (4.1% to 10%)	lung	15%  (9.9% to 20%)
GU tract	6.0%  (3.2% to 8.7%)	lymphoma/ leukaemia	80%  (4.1% to 12%)
melanoma	1.4%  (0.0% to 2.8%)	GI tract	4.3%  (1.4% to 7.2%)
mesothelioma	1.1%  (0.0% to 2.2%)	melanoma	3.2% (0.7% to 5.7%)
other tumours	3.5%  (1.4% to 5.6%)	urinary tract	1.1%  (0.0% to 2.5%)
primary site unknown	11%  (7.3% to 15%)	other tumours	1.6%  (0.0% to 3.4%)
.	.	primary site unknown	9.1%  (5.0% to 13%)